Patients Sue Two More Health Systems Over AI Scribe Use

Published Date: 17 Apr 2026

Months after a lawsuit against a San Diego health system, another class action alleges two more California health systems used Abridge’s AI tool to record patient visits without consent.

Read Full News

Latest News

Congo's Ebola Responders Decry Lack Of Medicine, Masks, Motorbikes

First responders fighting Democratic Republic of Congo's 17th Ebola outbreak say even basic supplies are scarce - from pain medicine, to motorbikes for contact tracing and...

Polypsychopharmacy on the Rise in Primary Care

A recent study shows that the concomitant use of two or more classes of psychotropic medication has risen among adult patients in Dutch primary care over a 10-year period.

A Post-Op Death, a Physician’s Personal Grief

Her brother’s death from a post-op pulmonary embolism left this cardiologist not only grieving but feeling guilty about the what-ifs.

10 Bucket List Vacation Ideas for Doctors

Discover the awe-inspiring destinations that top physicians' ultimate travel wish lists.

Medscape Dermatologist Compensation Report 2026

US dermatologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

High BMI, Low Activity Levels Linked to Chronic Pain

People with a high BMI or sedentary behavior have increased odds of experiencing chronic pain, although an interaction between these factors is not evident.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

First responders fighting Democratic Republic of Congo's 17th Ebola outbreak say even basic supplies are scarce - from pain medicine, to motorbikes for contact tracing and...

A recent study shows that the concomitant use of two or more classes of psychotropic medication has risen among adult patients in Dutch primary care over a 10-year period.

Her brother’s death from a post-op pulmonary embolism left this cardiologist not only grieving but feeling guilty about the what-ifs.

Discover the awe-inspiring destinations that top physicians' ultimate travel wish lists.

US dermatologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

People with a high BMI or sedentary behavior have increased odds of experiencing chronic pain, although an interaction between these factors is not evident.

News All Time

Medscape Gastroenterologist Compensation Report 2026

US gastroenterologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Family Physician Compensation Report 2026

US family physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Internist Compensation Report 2026

US internists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Endocrinologist Compensation Report 2026

US endocrinologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Emergency Medicine Physician Compensation Report 2026

US emergency medicine physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Cardiologist Compensation Report 2026

US cardiologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Polymyalgia Rheumatica: Key Symptoms and Treatment

Learn the key symptoms of polymyalgia rheumatica, as well as the overlap with giant cell arteritis.

Rates of Induced Labor Have Jumped in the Past Decade

Use of epidurals also on the rise

Hold GLP-1s Before Endoscopy? Clinical Trial Finds Retained Gastric Contents

Residual gastric volume precluded endoscopic examination

Knee Replacement: What Regional Pain Block Is Best for Outpatients?

Trial testing continuous versus single-shot adductor canal block produces a clear winner

Gabapentin, Pregabalin Increasingly Prescribed With Opioids

Millions of U.S. patients are still prescribed long-term opioids

Anesthesiologist Accused of Trying to Murder His Wife Convicted on Lesser Charge

Hawaii doctor's attorney plans to appeal

Jurors Deciding Whether Doctor Tried to Kill His Wife During a Hike in Hawaii

Gerhardt Konig is accused of having multiple plans to commit murder

Why Anesthesiologists Love Ketamine (And Why You Should Understand It)

Different doses lead to different effects on the body and the brain

Gabapentin, Pregabalin Tied to Higher Risks Early in Treatment

Drug poisoning rates rose, especially when used with other prescriptions

Building a Better Pre-Op Visit

It should never just be about checking a box

Recommended News For You

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

Adopted cancer cells and the effects of their presence.

Combo Therapy Boosts Early CML Response but Not Long Term

Pickleball program boosts health and wellness for cancer survivors, study finds

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

"We Caught It Early": Advantage or Disadvantage?

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

Recommended Articles For You

Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025 

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

1.

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options

2.

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment

3.

The New Era of Oncology: Key Updates and Clinical Insights

4.

HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option

5.

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot